NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.800
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
1.830
+0.030 (1.67%)
After-hours: Sep 4, 2026, 7:41 PM EDT
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $208.8 million as of September 4, 2026. Its market cap has decreased by -60.99% in one year.
Market Cap
208.80M
Enterprise Value
22.41M
1-Year Change
-60.99%
Ranking
Category
Stock Price
$1.80
ChartMarket Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $208.80M, an increase of 51.25%. That is a compound annual growth rate of 6.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 208.80M | -54.50% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 217.14M |
| Voyager Therapeutics | 216.28M |
| PepGen | 215.40M |
| Protalix BioTherapeutics | 215.13M |
| Corbus Pharmaceuticals Holdings | 214.30M |
| Minerva Neurosciences | 211.52M |
| Nkarta | 209.14M |
| Oramed Pharmaceuticals | 208.40M |